S&P 500   3,141.00 (-0.16%)
DOW   27,940.09 (-0.27%)
QQQ   204.65 (-0.17%)
AAPL   266.63 (-1.51%)
FB   202.17 (+0.56%)
MSFT   151.76 (+0.00%)
GOOGL   1,349.14 (+0.73%)
AMZN   1,753.19 (+0.09%)
CGC   20.98 (+12.49%)
MU   46.72 (-2.52%)
BABA   200.66 (-0.61%)
GE   11.03 (-0.63%)
TSLA   343.47 (+2.26%)
T   38.19 (-0.05%)
AMD   39.29 (-0.86%)
ACB   2.57 (+5.76%)
F   9.03 (+0.11%)
BAC   33.52 (-0.48%)
GILD   66.98 (-0.16%)
DIS   146.09 (-1.06%)
S&P 500   3,141.00 (-0.16%)
DOW   27,940.09 (-0.27%)
QQQ   204.65 (-0.17%)
AAPL   266.63 (-1.51%)
FB   202.17 (+0.56%)
MSFT   151.76 (+0.00%)
GOOGL   1,349.14 (+0.73%)
AMZN   1,753.19 (+0.09%)
CGC   20.98 (+12.49%)
MU   46.72 (-2.52%)
BABA   200.66 (-0.61%)
GE   11.03 (-0.63%)
TSLA   343.47 (+2.26%)
T   38.19 (-0.05%)
AMD   39.29 (-0.86%)
ACB   2.57 (+5.76%)
F   9.03 (+0.11%)
BAC   33.52 (-0.48%)
GILD   66.98 (-0.16%)
DIS   146.09 (-1.06%)
S&P 500   3,141.00 (-0.16%)
DOW   27,940.09 (-0.27%)
QQQ   204.65 (-0.17%)
AAPL   266.63 (-1.51%)
FB   202.17 (+0.56%)
MSFT   151.76 (+0.00%)
GOOGL   1,349.14 (+0.73%)
AMZN   1,753.19 (+0.09%)
CGC   20.98 (+12.49%)
MU   46.72 (-2.52%)
BABA   200.66 (-0.61%)
GE   11.03 (-0.63%)
TSLA   343.47 (+2.26%)
T   38.19 (-0.05%)
AMD   39.29 (-0.86%)
ACB   2.57 (+5.76%)
F   9.03 (+0.11%)
BAC   33.52 (-0.48%)
GILD   66.98 (-0.16%)
DIS   146.09 (-1.06%)
S&P 500   3,141.00 (-0.16%)
DOW   27,940.09 (-0.27%)
QQQ   204.65 (-0.17%)
AAPL   266.63 (-1.51%)
FB   202.17 (+0.56%)
MSFT   151.76 (+0.00%)
GOOGL   1,349.14 (+0.73%)
AMZN   1,753.19 (+0.09%)
CGC   20.98 (+12.49%)
MU   46.72 (-2.52%)
BABA   200.66 (-0.61%)
GE   11.03 (-0.63%)
TSLA   343.47 (+2.26%)
T   38.19 (-0.05%)
AMD   39.29 (-0.86%)
ACB   2.57 (+5.76%)
F   9.03 (+0.11%)
BAC   33.52 (-0.48%)
GILD   66.98 (-0.16%)
DIS   146.09 (-1.06%)
Log in

TSE:IMV - IMV Stock Price, Forecast & News

C$3.67
-0.04 (-1.08 %)
(As of 12/9/2019 01:34 PM ET)
Today's Range
C$3.61
Now: C$3.67
C$4.00
50-Day Range
C$2.97
MA: C$3.48
C$4.06
52-Week Range
C$2.77
Now: C$3.67
C$7.93
Volume92,186 shs
Average Volume41,581 shs
Market CapitalizationC$185.82 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
IMV Inc, a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The company's DPX drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-902-4921819

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$59,000.00
Cash FlowC$0.43 per share
Book ValueC$0.29 per share

Profitability

Miscellaneous

Employees51
Market CapC$185.82 million
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable

Receive IMV News and Ratings via Email

Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter.


IMV (TSE:IMV) Frequently Asked Questions

What is IMV's stock symbol?

IMV trades on the Toronto Stock Exchange (TSX) under the ticker symbol "IMV."

How were IMV's earnings last quarter?

Imv Inc (TSE:IMV) issued its earnings results on Friday, November, 8th. The company reported ($0.16) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.12) by $0.04. The company had revenue of $0.16 million for the quarter, compared to analyst estimates of $0.06 million. View IMV's Earnings History.

When is IMV's next earnings date?

IMV is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for IMV.

What price target have analysts set for IMV?

5 brokerages have issued twelve-month target prices for IMV's stock. Their forecasts range from C$9.00 to C$10.50. On average, they expect IMV's share price to reach C$9.75 in the next twelve months. This suggests a possible upside of 165.7% from the stock's current price. View Analyst Price Targets for IMV.

What is the consensus analysts' recommendation for IMV?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMV in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for IMV.

Has IMV been receiving favorable news coverage?

News stories about IMV stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. IMV earned a coverage optimism score of -1.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for IMV.

Who are some of IMV's key competitors?

What other stocks do shareholders of IMV own?

Who are IMV's key executives?

IMV's management team includes the folowing people:
  • Mr. Frederic Ors, Pres, CEO & Director (Age 45)
  • Mr. Pierre Labbé C.A., C.P.A., CPA, CA, ICD, Chief Financial Officer (Age 54)
  • Dr. Gabriela Nicola Rosu M.D., Chief Medical Officer
  • Mr. Joseph Sullivan, Sr. VP of Bus. Devel.
  • Mr. Marc Jasmin CPA, CMA, Sr. Director of Investor Relations & Communications

How do I buy shares of IMV?

Shares of IMV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is IMV's stock price today?

One share of IMV stock can currently be purchased for approximately C$3.67.

How big of a company is IMV?

IMV has a market capitalization of C$185.82 million and generates C$59,000.00 in revenue each year. IMV employs 51 workers across the globe.View Additional Information About IMV.

What is IMV's official website?

The official website for IMV is http://www.imvaccine.com/.

How can I contact IMV?

IMV's mailing address is 1344 Summer Street, Suite 412, HALIFAX, NS B3H 0A8, Canada. The company can be reached via phone at +1-902-4921819.


MarketBeat Community Rating for IMV (TSE IMV)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about IMV and other stocks. Vote "Outperform" if you believe IMV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel